These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21218662)

  • 41. [Pathophysiology and treatment of secondary hyperuricemia].
    Tsutani H
    Nihon Rinsho; 2008 Apr; 66(4):699-704. PubMed ID: 18409518
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hyperuricemia and gout in an employee population.
    Thorpe JJ; Daley JM
    J Occup Med; 1971 Nov; 13(11):524-34. PubMed ID: 5134350
    [No Abstract]   [Full Text] [Related]  

  • 43. [Drug-induced hyperuricemia].
    Hamada T; Hisatome I; Shigemasa C
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():333-7. PubMed ID: 12629742
    [No Abstract]   [Full Text] [Related]  

  • 44. Control of renal uric acid excretion and gout.
    Taniguchi A; Kamatani N
    Curr Opin Rheumatol; 2008 Mar; 20(2):192-7. PubMed ID: 18349750
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical aspects of monosodium urate monohydrate crystal deposition disease (gout).
    Becker MA
    Rheum Dis Clin North Am; 1988 Aug; 14(2):377-94. PubMed ID: 3051156
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Understanding treatments for gout.
    Cannella AC; Mikuls TR
    Am J Manag Care; 2005 Nov; 11(15 Suppl):S451-8; quiz S465-8. PubMed ID: 16300459
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hyperlipidemia and obesity].
    Ishigami M; Matsuzawa Y
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():241-6. PubMed ID: 12629725
    [No Abstract]   [Full Text] [Related]  

  • 48. Case 3: acute gout-risk factors and inappropriate therapy.
    Weaver AL
    Am J Med; 2006 Nov; 119(11 Suppl 1):S9-12. PubMed ID: 17059914
    [No Abstract]   [Full Text] [Related]  

  • 49. Hyperuricemia and tissue monourate deposits: prospective therapeutic considerations.
    Perez-Ruiz F; Punzi L
    Eur Rev Med Pharmacol Sci; 2015; 19(9):1549-52. PubMed ID: 26004589
    [No Abstract]   [Full Text] [Related]  

  • 50. Homozygous frameshift mutation in the SLC22A12 gene in a patient with primary gout and high levels of serum uric acid.
    Vázquez-Mellado J; Alvarado-Romano V; Burgos-Vargas R; Jiménez-Vaca AL; Pozo-Molina G; Cuevas-Covarrubias SA
    J Clin Pathol; 2007 Aug; 60(8):947-8. PubMed ID: 17660342
    [No Abstract]   [Full Text] [Related]  

  • 51. [Physiology and dynamics of uric acid in hyperuricemia].
    Takagi K; Nakamura T; Ueda T
    Nihon Rinsho; 2008 Apr; 66(4):669-74. PubMed ID: 18409512
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rules of engagement: turning recommendations into results in the diagnosis and management of gout.
    Grainger R; Harrison AA
    Int J Rheum Dis; 2015 Mar; 18(3):261-3. PubMed ID: 25923604
    [No Abstract]   [Full Text] [Related]  

  • 53. [Therapy of hyperuricemia and gout].
    Pöllmann G; Kullich W; Klein G
    Wien Med Wochenschr; 1997; 147(16):382-7. PubMed ID: 9446417
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hyperuricemia and associated diseases.
    Becker MA; Jolly M
    Rheum Dis Clin North Am; 2006 May; 32(2):275-93, v-vi. PubMed ID: 16716880
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Austrian nutrition and lifestyle recommendations for gout and hyperuricemia].
    Sautner J; Eichbauer-Sturm G; Gruber J; Puchner R; Spellitz P; Strehblow C; Zwerina J; Eberl G;
    Z Rheumatol; 2015 Sep; 74(7):631-6. PubMed ID: 26014619
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bibliography. Current world literature. Crystal deposition diseases.
    Curr Opin Rheumatol; 2007 Mar; 19(2):225-7. PubMed ID: 17340789
    [No Abstract]   [Full Text] [Related]  

  • 57. Metabolic syndrome characteristics in gout patients.
    Fraile JM; Torres RJ; de Miguel ME; Martínez P; Lundelin KJ; Vázquez JJ; Puig JG
    Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):325-9. PubMed ID: 20544515
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Idiopathic retroperitoneal fibrosis and hyperuricemia].
    Mineo I; Nakagawa C; Tarui S
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():328-32. PubMed ID: 12629741
    [No Abstract]   [Full Text] [Related]  

  • 59. Gout in renal allograft recipients according to the pretransplant hyperuricemic status.
    Hernández-Molina G; Cachafeiro-Vilar A; Villa AR; Alberú J; Rull-Gabayet M
    Transplantation; 2008 Dec; 86(11):1543-7. PubMed ID: 19077887
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnosis of gout.
    Schlesinger N
    Minerva Med; 2007 Dec; 98(6):759-67. PubMed ID: 18299687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.